Aurora Cannabis to Hold Third Quarter Investor Teleconference 2019 May 15, 2019

TSX: ACB | NYSE: ACB

<p class = "canvas-atom web-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "EDMONTON, May 6, 2019 / CNW / – Aurora Cannabis Inc. ("Aurora" or "the company") (CBA) (CBA) (Frankfurt: 21P; WKN: A1C4WM), today announced the holding of its teleconference to discuss the results of the third quarter ended March 31, 2019. The call will be held on Wednesday, May 15. ^th, 2019 at 10:30 am, Eastern Time, by Terry Booth, General Manager, Glen Ibbott, Chief Financial Officer, Cam Battley, General Manager, and Michael Singer, Executive Chairman, followed by a question and answer period. The company will report its third quarter financial results after market close on Tuesday, May 14. ^th, 2019 "data-reactid =" 12 "> EDMONTON, May 6, 2019 / CNW / – Aurora Cannabis Inc. (" Aurora "or" the Company ") (ACB) (ACB) (Frankfurt: 21P; WKN: A1C4WM) , announced today that it has scheduled its teleconference to discuss the results for the third quarter ended March 31, 2019. This conference call will be held on Wednesday, May 15. ^th, 2019 at 10:30 am, Eastern Time, by Terry Booth, General Manager, Glen Ibbott, Chief Financial Officer, Cam Battley, General Manager, and Michael Singer, Executive Chairman, followed by a question and answer period. The company will report its third quarter financial results after market close on Tuesday, May 14. ^th, 2019

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "About Aurora & nbsp;"data-reactid =" 16 ">About Aurora

Headquartered in Edmonton, Alberta, Canada, with over 625,000 kg of financing capacity and sales and operations in 24 countries on five continents, Aurora is one of the largest and most important cannabis companies in the world. Aurora is vertically integrated and horizontally diversified across all key segments of the value chain, from engineering and facility design to research on cannabis selection and genetics, cannabis production and hemp, derivatives, development of high added value products, home grown, wholesale and retail.

Highly differentiated from its peers, Aurora has implemented a particularly advanced, consistent and efficient production strategy, based on facilities specifically designed to integrate state-of-the-art technologies into all processes, defined by extensive automation and customization, enabling large-scale production of low-cost quality. Designed to be replicated and scalable globally, our production facilities are designed to produce cannabis on a significant scale, with high quality, industry leading yields, and low production costs per gram. Each Aurora facility is built to meet European GMP standards. The EU GMP certification has been awarded to Aurora's first production facility in Mountain View County, to the MedReleaf Markham facility, and to its European medical cannabis distributor, Aurora Deutschland.

<p class = "web-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "In addition to the rapid organic growth of society and its strong execution on strategic M & A, which to date includes 15 fully controlled subsidiaries – MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland, H2 Biopharma, Urban Grower, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia, HotHouse Consulting, MED Colombia, Agropro, Borela, ICC Labs and Chemi Pharmaceutical – Aurora stands out by its reputation as a partner and employer of choice in the global cannabis industry, having invested in and established strategic partnerships with a range of leading innovators, including Radient Technologies Inc. (RTI.V), Hempco Food and Fiber Inc. (HEMP.V), Cann Group Ltd. (CAN.AX), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Capcium Inc. (private), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (CTTH), Alcanna Inc. (CLIQ.TOHigh Tide Inc. (CSE: HITI) and EnWave Corporation (ENW.V). "data-reactid =" 19 "> In addition to the company's rapid internal growth and strong execution in strategic mergers and acquisitions, which to date includes 15 wholly-owned subsidiaries – MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland, H2 Biopharma , Urban Cultivator, British Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia, HotHouse Consulting, MED Colombia, Agropro, Borela, ICC Labs and Chemi Pharmaceutical – Aurora stands out for its reputation as a partner and employer of choice in the Global cannabis industry, having invested and established strategic partnerships with a range of leading innovators including: Radient Technologies Inc. (RTI.V), Hempco Food and Fiber Inc. (HEMP.V), Cann Group Ltd. (CAN.AX), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Capcium Inc. (private), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (CTTH), Alcanna Inc. (CLIQ .TO), High Tide Inc. (CSE: HITI) and EnWave Corporation (ENW.V).

The Aurora common shares trade on the TSX and the NYSE under the symbol "ACB" and are part of the S & P / TSX Composite Index.

For more information on Aurora, please visit our investor website, investor.auroramj.com

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Terry Booth, CEO
Aurora Cannabis Inc. "data-reactid =" 22 "> Terry Booth, CEO
Aurora Cannabis Inc.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Forward-looking statements & nbsp;"data-reactid =" 23 ">Forward-looking statements

This press release contains statements containing certain "forward-looking information" within the meaning of applicable securities laws ("forward-looking statements"). Forward-looking statements are often characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate" "," may "," may "," may "," potential "," proposed "and similar words, or statements that certain events or conditions" may "or" will "occur. These statements are only predictions. Various assumptions have been used to draw the conclusions or projections contained in the forward-looking statements throughout this press release. Forward-looking statements are based on management's beliefs and beliefs as of the date they are made and are subject to various risks, uncertainties and other factors that could cause actual events to differ materially from those projected. in the future. statements-looking. The Company has no obligation and expressly disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. .

The story continues